Agnès Caille

2.2k total citations
77 papers, 1.2k citations indexed

About

Agnès Caille is a scholar working on Statistics, Probability and Uncertainty, Statistics and Probability and Economics and Econometrics. According to data from OpenAlex, Agnès Caille has authored 77 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Statistics, Probability and Uncertainty, 18 papers in Statistics and Probability and 13 papers in Economics and Econometrics. Recurrent topics in Agnès Caille's work include Meta-analysis and systematic reviews (18 papers), Statistical Methods in Clinical Trials (12 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). Agnès Caille is often cited by papers focused on Meta-analysis and systematic reviews (18 papers), Statistical Methods in Clinical Trials (12 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). Agnès Caille collaborates with scholars based in France, Canada and United Kingdom. Agnès Caille's co-authors include Bruno Giraudeau, Clémence Leyrat, L. Machet, N. Bénéton, Lobna Ouldamer, H. Maillard, G. Body, Guido Bens, David Jacobi and Sandra Eldridge and has published in prestigious journals such as PLoS ONE, PEDIATRICS and BMJ.

In The Last Decade

Agnès Caille

73 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agnès Caille France 19 239 199 176 152 137 77 1.2k
Julie Pildal Denmark 9 68 0.3× 272 1.4× 197 1.1× 324 2.1× 72 0.5× 13 2.0k
Chizobam Ani United States 16 293 1.2× 80 0.4× 115 0.7× 101 0.7× 58 0.4× 31 942
Guo‐Wen Sun United States 9 78 0.3× 90 0.5× 98 0.6× 187 1.2× 57 0.4× 14 1.0k
Geneviève Grégoire Canada 5 56 0.2× 143 0.7× 136 0.8× 281 1.8× 43 0.3× 8 1.3k
Stella Leung Canada 24 201 0.8× 145 0.7× 282 1.6× 532 3.5× 68 0.5× 49 2.5k
Radoslav Latinovic United Kingdom 21 156 0.7× 153 0.8× 226 1.3× 424 2.8× 32 0.2× 27 1.8k
Rasheda Rabbani Canada 18 145 0.6× 246 1.2× 167 0.9× 224 1.5× 68 0.5× 71 1.5k
Murtuza Bharmal United States 18 725 3.0× 83 0.4× 122 0.7× 127 0.8× 28 0.2× 86 1.8k
Yihe G. Daida United States 19 119 0.5× 251 1.3× 131 0.7× 125 0.8× 131 1.0× 95 1.5k
Kay Ryschon United States 21 140 0.6× 78 0.4× 351 2.0× 150 1.0× 74 0.5× 44 1.7k

Countries citing papers authored by Agnès Caille

Since Specialization
Citations

This map shows the geographic impact of Agnès Caille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Caille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Caille more than expected).

Fields of papers citing papers by Agnès Caille

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Caille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Caille. The network helps show where Agnès Caille may publish in the future.

Co-authorship network of co-authors of Agnès Caille

This figure shows the co-authorship network connecting the top 25 collaborators of Agnès Caille. A scholar is included among the top collaborators of Agnès Caille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnès Caille. Agnès Caille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferreira, Marion, Théodora Bejan‐Angoulvant, S. Marchand‐Adam, et al.. (2024). Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trial. Respiratory Medicine and Research. 87. 101144–101144. 1 indexed citations
2.
Caille, Agnès, Myriam Blanchin, Anne Sauvaget, et al.. (2023). EMDR for symptoms of depression, stress and burnout in health care workers exposed to COVID-19 (HARD): A study protocol for a trial within a cohort study. European journal of psychotraumatology. 14(1). 2179569–2179569. 4 indexed citations
4.
Smaïl‐Faugeron, Violaine, Aidan Lyanzhiang Tan, Agnès Caille, et al.. (2022). Meta-analyses frequently include old trials that are associated with a larger intervention effect: a meta-epidemiological study. Journal of Clinical Epidemiology. 145. 144–153. 8 indexed citations
5.
6.
Giraudeau, Bruno, Agnès Caille, Sandra Eldridge, et al.. (2022). Heterogeneity in pragmatic randomised trials: sources and management. BMC Medicine. 20(1). 372–372. 22 indexed citations
7.
Gouge, Amélie Le, et al.. (2021). Combining Trauma Script Exposure With rTMS to Reduce Symptoms of Post-Traumatic Stress Disorder: Randomized Controlled Trial. Neuromodulation Technology at the Neural Interface. 25(4). 549–557. 16 indexed citations
8.
Caille, Agnès, et al.. (2021). Methodological review showed that time-to-event outcomes are often inadequately handled in cluster randomized trials. Journal of Clinical Epidemiology. 134. 125–137. 8 indexed citations
9.
Leducq, Sophie, Agnès Caille, Laurence Le Cleach, et al.. (2020). Research Techniques Made Simple: Randomized Controlled Trials for Topical Drugs in Dermatology: When and How Should We Use a Within-Person Design?. Journal of Investigative Dermatology. 140(5). 931–938.e1. 6 indexed citations
11.
Kervarrec, Thibault, Pauline Gaboriaud, Patricia Berthon, et al.. (2020). Merkel cell carcinoma of lymph nodes without a skin primary tumor: A potential metastatic neoplasia associated with a brisk immune response. Journal of the American Academy of Dermatology. 83(6). 1789–1792. 2 indexed citations
13.
Caille, Agnès, Sally Kerry, Elsa Tavernier, et al.. (2016). Timeline cluster: a graphical tool to identify risk of bias in cluster randomised trials. BMJ. 354. i4291–i4291. 38 indexed citations
14.
Sautenet, Bénédicte, Jean‐Michel Halimi, Agnès Caille, & Bruno Giraudeau. (2015). Les critères de jugement dans les essais randomisés : typologie, pertinence et importance de leur standardisation. Exemple de la néphroprotection. La Presse Médicale. 44(11). 1096–1102. 1 indexed citations
15.
Caille, Agnès, et al.. (2015). High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma. British Journal of Dermatology. 174(1). 146–151. 123 indexed citations
16.
Caille, Agnès, et al.. (2015). Unbalanced rather than balanced randomized controlled trials are more often positive in favor of the new treatment: an exposed and nonexposed study. Journal of Clinical Epidemiology. 68(8). 944–949. 7 indexed citations
17.
Ouldamer, Lobna, Agnès Caille, Bruno Giraudeau, & G. Body. (2015). Quilting Suture of Mastectomy Dead Space Compared with Conventional Closure with Drain. Annals of Surgical Oncology. 22(13). 4233–4240. 44 indexed citations
18.
Caille, Agnès, et al.. (2014). Rationale for unequal randomization in clinical trials is rarely reported: a systematic review. Journal of Clinical Epidemiology. 67(10). 1070–1075. 16 indexed citations
19.
Ouldamer, Lobna, Agnès Caille, & G. Body. (2013). Fallopian Tube Prolapse after Hysterectomy: A Systematic Review. PLoS ONE. 8(10). e76543–e76543. 11 indexed citations
20.
Sautenet, Bénédicte, Agnès Caille, Jean‐Michel Halimi, Philippe Goupille, & Bruno Giraudeau. (2013). Better reporting and greater homogeneity in outcome measures are seen in randomized trial protocols when guidelines exist. Journal of Clinical Epidemiology. 66(8). 838–846. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026